While we do not conduct in-house manufacturing, we actively collaborate with global pharmaceutical manufacturers and research institutions to stay at the forefront of medical advancements. Our current research-related activities include:

​

• Product Sourcing: Identifying and importing cutting-edge pharmaceutical products that address the most pressing health challenges in Liberia, such as malaria, HIV/AIDS, and chronic diseases.

• Clinical Trials Support: Partnering with international manufacturers and local healthcare providers to facilitate clinical trials in Liberia, ensuring that new treatments are safe and effective for the local population.

• Market Research: Conducting comprehensive market research to understand the healthcare needs of the Liberian population and to identify the most promising new products for importation.

Our role as an importer allows us to bring the latest pharmaceutical innovations to Liberia. We focus on sourcing products that leverage the latest technologies and scientific advancements, including:

​

• Advanced Drug Formulations: Importing innovative drug formulations that offer improved efficacy, safety, and patient compliance.

• Biologics and Biosimilars: Sourcing advanced biologics and biosimilars to provide cutting-edge treatments for complex conditions such as cancer and autoimmune diseases.

• Digital Health Solutions: Partnering with manufacturers to bring digital health solutions, such as telemedicine platforms and health monitoring devices, to enhance healthcare delivery in Liberia.

Collaboration is key to our success in R&D. We partner with leading research institutions, universities, and healthcare organizations to drive innovation and achieve our goals. Our partnerships include:

​

• Academic Collaborations: Working with top universities and research institutions to access the latest scientific knowledge and to support the introduction of new treatments in Liberia.

• Industry Partnerships: Collaborating with global pharmaceutical companies to bring their latest products to the Liberian market, ensuring that patients have access to the best available treatments.

• Public-Private Partnerships: Engaging with government agencies and non-profit organizations to address public health challenges and advance global health initiatives.

• Clinical Research Organizations (CROs): Partnering with CROs to support clinical research and trials in Liberia, ensuring rigorous testing and validation of new drug candidates.